Dr. Daniel Abate Daga, PhD

Claim this profile

Moffitt Cancer Center

Studies Lung Cancer
Studies Non-small Cell Lung Cancer (NSCLC)
1 reported clinical trial
2 drugs studied

Area of expertise

1

Lung Cancer

Daniel Abate Daga, PhD has run 1 trial for Lung Cancer. Some of their research focus areas include:

Stage IV
ROS1 positive
HER2 positive
2

Non-small Cell Lung Cancer (NSCLC)

Daniel Abate Daga, PhD has run 1 trial for Non-small Cell Lung Cancer (NSCLC). Some of their research focus areas include:

Stage IV
ROS1 positive
HER2 positive

Affiliated Hospitals

Image of trial facility.

Moffitt Cancer Center

More about Daniel Abate Daga, PhD

Clinical Trial Related

2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials

Treatments Daniel Abate Daga, PhD has experience with

  • Nivolumab
  • Tumor-infiltrating Lymphocytes (TIL)

Breakdown of trials Daniel Abate Daga, PhD has run

Non-small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Daniel Abate Daga, PhD specialize in?

Is Daniel Abate Daga, PhD currently recruiting for clinical trials?

Are there any treatments that Daniel Abate Daga, PhD has studied deeply?

What is the best way to schedule an appointment with Daniel Abate Daga, PhD?

What is the office address of Daniel Abate Daga, PhD?

Is there any support for travel costs?